Author:
Lazar Eric S.,Stankus Nicole
Reference20 articles.
1. K/DOQI Clinical Practice Guidelines: bone metabolism and disease in chronic kidney disease;National Kidney Foundation;Am J Kidney Dis,2003
2. Extracellular calcium-sensing receptors in the parathyroid gland, kidney, and other tissues;Quarles;Curr Opin Nephrol Hypertens,2003
3. The impact of calcimimetic agents on the use of different classes of phosphate binders: results of recent clinical trials;Szczech;Kidney Int,2004
4. Achieving NKF-K/DOQI bone metabolism and disease treatment goals with cinacalcet HCl;Moe;Kidney Int,2005
5. Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis patients: a randomized, double-blind, multicenter study;Lindberg;J Am Soc Nephrol,2005
Cited by
28 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献